scholarly journals Casein hydrolysates as a source of antimicrobial, antioxidant and antihypertensive peptides

2007 ◽  
Vol 87 (4-5) ◽  
pp. 241-249 ◽  
Author(s):  
Iván López-Expósito ◽  
Ana Quirós ◽  
Lourdes Amigo ◽  
Isidra Recio
2020 ◽  
Vol 17 (2) ◽  
pp. 85-91
Author(s):  
Chandra Utami Wirawati ◽  
Dwi Eva Nirmagustina ◽  
Yatim Rahayu Widodo

2019 ◽  
pp. 200-202
Author(s):  
Claudia Traidl-Hoffmann

Introduction: Cowʼs milk allergy (CMA) is a common diagnosis in infants, requiring the exclusion of cowʼs milk until tolerance is recovered. In the present study, we aim to determine which factors are associated with the development of tolerance.Methods: Retrospective, observational study of subjects who underwent the same clinical follow-up methodology. We studied 245 cases of CMA (125 IgE-mediated and 120 non-IgE-mediated). The following variables were analysed: age at diagnosis, gender, type of delivery, type of feeding received, feeding during the first months of life, clinical features, and type of feed received as treatment: casein hydrolysates or casein hydrolysates with Lactobacillus rhamnosus GG (LGG).Results: Factors associated with earlier tolerance were non-IgE-mediated CMA (HR = 2.92; 95% CI: 2.20-3.88) and patients receiving casein hydrolysate with LGG (HR = 1.79; 95% CI: 1.33-2.42). Later tolerance was associated with caesarean delivery (HR = 0.78; 95% CI: 0.58-1.05) and breastfeeding for a period of at least 3 days (HR = 0.64; 95% CI: 0.44-0.93). The multivariate study shows that the type of formula (HR = 1.61; 95% CI: 1.19-2.18) and the type of CMA (HR = 2.82; 95% CI: 2.12-3.85) have an effect on the recovery time. Casein hydrolysates with LGG reduces the recovery time in IgE-mediated (HR = 1.88; 95% CI: 1.17-3.01) and non-IgE-mediated CMA (HR = 1.46; 95% CI: 0.98-2.17).Conclusion: Tolerance acquisition is faster in non-IgE-mediated CMA subjects and in those who received casein hydrolysate with LGG.


2015 ◽  
Vol 74 (OCE4) ◽  
Author(s):  
M. Cermeño ◽  
Y. O'Callaghan ◽  
N. O'Brien ◽  
R.J. FitzGerald
Keyword(s):  

Life Sciences ◽  
2013 ◽  
Vol 93 (25-26) ◽  
pp. e43
Author(s):  
Hsiao-Ling Chen ◽  
Yu-Tang Tung ◽  
Geroge Kuo ◽  
Chuan-Mu Chen

PEDIATRICS ◽  
1958 ◽  
Vol 21 (6) ◽  
pp. 929-940
Author(s):  
Helen K. Berry ◽  
Betty S. Sutherland ◽  
George M. Guest ◽  
Barbara Umbarger

Three children with phenylketonuria between the ages of 2½ and 4½ years have been treated with three different diets low in content of phenylalanine during the past 18 months. In Diets I and III restriction of phenylalanine was accomplished by use of casein hydrolysates from which phenylalanine had been removed and other amino acids added. In Diet II intake of phenylalanine was limited by restriction of total intake of protein in the diet. Diets II and III were commercial preparations. All diets were fed in semisolid form combined with natural foods. After an initial period of hospitalization for regulation of intake of phenylalanine, treatment was carried out at home. Except during the early months of treatment intake of phenylalanine was not severely restricted. Nutritional disturbances were encountered as a result of apparent amino acid deficiencies in Diet I. Inadequate caloric intake and low intake of protein also contributed to poor nutritional status at one stage in the treatment. Biochemical abnormalities characteristic of phenylketonuria were improved when phenylalanine was restricted in the diets of the three children. All three showed improvement in motor ability, increased awareness, lengthened attention span, decreased tenseness and irritability. No change in mental status on objective testing was demonstrated. The improvement in behavior motor control, and ease of handling was such that the parents were unwilling for the children to receive diets with normal content of phenylalanine. This reaction of the parents should be taken into consideration whenever administration of a diet low in content of phenylalanine is considered.


2005 ◽  
pp. 143-151
Author(s):  
Jacqueline Gallagher ◽  
Ara D. Kanekanian ◽  
E. Peter Evans
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document